Two incidents of shared delusions are presented, one between two brothers and the other between an elderly couple. Their presentation and management are discussed. The possible role of projection and overvalued ideas as aetiological factors in Nigerians with shared delusions are highlighted.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Very Early-Onset Schizophrenia with Accompanying Obsessive-Compulsive Symptoms: A Case Report of a Female with 16p13.11 Duplication.
Psychiatry Clin Psychopharmacol
November 2024
Department of Child and Adolescent Psychiatry, University of Health Sciences, Bakırköy Prof. Dr. Mazhar Osman Training and Research Hospital for Psychiatry, Neurology and Neurosurgery, İstanbul, Türkiye.
Article Synopsis
- - Psychosis is a complex mental disorder characterized by disruptions in perception and thinking, leading to hallucinations and delusions, complicating diagnosis and treatment due to overlaps with other conditions like OCD.
- - Recent studies aim to pinpoint genetic and biochemical markers, particularly focusing on the 16p13.11 chromosomal region, which has been linked to various neurodevelopmental disorders including schizophrenia.
- - A case of a 12-year-old girl with early-onset schizophrenia and additional conditions highlights the need for a thorough evaluation and a multidisciplinary management approach to improve diagnosis and treatment strategies for complex cases.
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases (ERN-RND).
Eur J Neurol
December 2024
Department of Neurology, University Hospital Leuven, Leuven, Belgium.
Background And Purpose: Frontotemporal dementia (FTD) is a neurodegenerative disorder characterized by pervasive personality and behavioural disturbances with severe impact on patients and caregivers. In current clinical practice, treatment is based on nonpharmacological and pharmacological approaches. Unfortunately, trial-based evidence supporting symptomatic pharmacological treatment for the behavioural disturbances in FTD is scarce despite the significant burden this poses on the patients and caregivers.
View Article and Find Full Text PDFIntroducing S.C.O.P.E.™ (Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement), an Interactive Digital Platform to Educate Healthcare Professionals on Schizophrenia Care.
Neuropsychiatr Dis Treat
October 2024
Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Despite evidence of benefits beyond those of oral antipsychotics, long-acting injectable antipsychotics (LAIs) are underused in schizophrenia treatment. Underuse may be partially a result of misconceptions held by some healthcare professionals (HCPs) pertaining to LAIs. A panel of four experts convened between January 2022 and May 2022 to identify these misconceptions, and example cases or scenarios were created to illustrate common clinical situations relevant to these beliefs.
View Article and Find Full Text PDFEvaluating pimavanserin tartrate as a treatment in Parkinson's disease.
Expert Opin Pharmacother
October 2024
Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Berlin, Germany.
Article Synopsis
- Pimavanserin is an atypical neuroleptic specifically designed to treat hallucinations and delusions in Parkinson's disease patients, without worsening their motor symptoms, unlike traditional antipsychotics.
- This drug works by targeting serotonin receptors instead of dopamine receptors, which helps manage psychosis in those on dopamine treatments.
- As it gains more recognition, especially once it becomes available as a generic drug, pimavanserin might become more popular compared to other alternatives like quetiapine and clozapine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!